Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 148.18 USD | +2.08% |
|
+1.69% | +69.66% |
| Market Cap | 9.59B 8.26B 7.82B 7.09B 13.3B 916B 13.37B 92.91B 35.73B 466B 36.01B 35.22B 1,473B | P/E 2026 * |
31.9x | P/E 2027 * | -312x |
|---|---|---|---|---|---|
| Enterprise Value | 9.05B 7.8B 7.38B 6.69B 12.56B 865B 12.62B 87.69B 33.72B 440B 33.99B 33.24B 1,390B | EV / Sales 2026 * |
16.7x | EV / Sales 2027 * | 44.6x |
| Free-Float |
97.68% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTGX | Delayed | |
CBOE
| PTGX | Real-time | |
|
Tradegate
| PGF | Real-time |
Last Transcript : Protagonist Therapeutics, Inc.
| 1 day | +2.08% | ||
| 1 week | +1.69% | ||
| Current month | +0.29% | ||
| 1 month | -0.07% | ||
| 3 months | +34.97% | ||
| 6 months | +53.59% | ||
| Current year | +69.66% |
| 1 week | 142 |  | 151.18 |
| 1 month | 141.95 | | 160.81 |
| Current year | 77 | | 160.81 |
| 1 year | 57.9 | | 160.81 |
| 3 years | 13.72 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/09/26 | Exercice | Chief Executive Officer | 21,834 | 0.0337% | ||
| 03/09/26 | Don | Chief Executive Officer | -510 | 0.0008% | ||
| 11/08/26 | Exercice | Chief Executive Officer | 102,717 | 0.1597% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.08% | +1.69% | +148.29% | +685.68% | 9.59B | |
| -0.71% | -6.35% | -4.87% | +9.03% | 45.48B | |
| +0.21% | -2.98% | +340.68% | +519.93% | 43.69B | |
| +1.74% | -2.24% | +37.28% | +21.57% | 43.09B | |
| +1.38% | -3.28% | +3.23% | +65.60% | 39.4B | |
| -1.44% | -5.26% | +8.78% | +36.85% | 31.91B | |
| +0.87% | -2.60% | - | - | 17.31B | |
| +0.75% | -0.64% | +18.07% | +110.32% | 16.4B | |
| -0.31% | -2.78% | +10.47% | +30.49% | 14.24B | |
| +1.93% | -3.55% | +74.20% | +39.37% | 13.28B | |
| Average | +0.65% | -3.05% | +70.68% | +168.76% | 27.44B | |
| Weighted average by Cap. | +0.47% | -3.48% | +75.96% | +144.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 542M 467M 442M 401M 752M 51.81B 756M 5.25B 2.02B 26.36B 2.04B 1.99B 83.28B | 203M 175M 166M 150M 282M 19.43B 284M 1.97B 758M 9.89B 764M 747M 31.24B |
| Net income | 324M 279M 264M 239M 449M 30.93B 451M 3.14B 1.21B 15.74B 1.22B 1.19B 49.72B | -32.12M -27.68M -26.21M -23.75M -44.56M -3.07B -44.79M -311M -120M -1.56B -121M -118M -4.93B |
| Net Debt | -538M -464M -439M -398M -747M -51.42B -750M -5.22B -2.01B -26.16B -2.02B -1.98B -82.67B | -511M -440M -417M -378M -709M -48.83B -713M -4.95B -1.9B -24.84B -1.92B -1.88B -78.49B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | US$148.18 | +2.08% | 478,038 |
| 10/09/26 | US$145.16 | +0.05% | 543,129 |
| 09/09/26 | US$145.09 | -0.58% | 530,534 |
| 08/09/26 | US$145.94 | +0.15% | 700,126 |
| 04/09/26 | US$145.72 | -2.07% | 501,305 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
